"The Regulatory Accountability Act of 2017 - Implications for FDA Regulation and Public Health" by Jonathan J. Darrow

Works of Erin C. Fuse Brown

Follow Contact

Article

The Regulatory Accountability Act of 2017 - Implications for FDA Regulation and Public Health

New England Journal of Medicine

Jonathan J. Darrow
Erin C. Fuse Brown, Georgia State University College of Law
Aaron S. Kesselheim, Brigham and Women's Hospital, Harvard Medical School

Link

Document Type

Article

Publication Date

2-1-2018

Disciplines

Administrative Law,
Food and Drug Law,
Health Law and Policy,
Health Policy,
Law,
Other Public Health,
Public Affairs, Public Policy and Public Administration,
Public Health and
Public Policy

Comments

External Links

Westlaw

DOI

10.1056/NEJMp1711643

Citation Information

Jonathan J. Darrow, Erin C. Fuse Brown, & Aaron S. Kesselheim, The Regulatory Accountability Act of 2017 - Implications for FDA Regulation and Public Health, 378 N. Eng. J. Med. 412 (2018).